ACP
ZGNX

Acuta Capital Partners’s Zogenix, Inc. ZGNX Stock Holding History

Acuta Capital Partners’s Portfolio ZGNX Stock Details ZGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-82,500
Closed -$3.65M – 60
2018
Q2 		$3.65M Buy
+82,500
New +$3.4M 0.65% 30

Other funds holding ZGNX

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acuta Capital Partners's ZGNX Position: Q3 2018 in Review

Acuta Capital Partners sold out of Zogenix, Inc. (ZGNX) in Q3 2018, closing a stake of 110,500 shares — an estimated $4.88M sold.

Acuta Capital Partners first reported a position in ZGNX in Q1 2017 and held it in 5 quarters. The position peaked at $12M in Q4 2017. 170 funds tracked by Wall St. Rank hold ZGNX as of Q3 2018.

  • Acuta Capital Partners reported no remaining Zogenix, Inc. position as of Q3 2018 after selling out during the quarter.
  • Acuta Capital Partners sold 110,500 Zogenix, Inc. shares in Q3 2018, an estimated $4.88M.
  • Acuta Capital Partners first reported a position in Zogenix, Inc. in Q1 2017 and held it in 5 quarters.
  • Acuta Capital Partners's Zogenix, Inc. position peaked at $12M in Q4 2017.
  • 170 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q3 2018.

Based on Acuta Capital Partners's 13F filing for Q3 2018, filed 7 Nov 2018.